Literature DB >> 1520246

Frequency-dependent action of antiarrhythmic drugs: the useful concept of periodical ligand binding.

J Weirich.   

Abstract

The action of most antiarrhythmic drugs which block cardiac ionic channels depends on heart rate, which is established as use- or frequency-dependence. This property is consistent with periodical drug (ligand) binding to channel binding sites which are transiently available during the excitation sequence of cardiac tissue. Antiarrhythmic drugs differ with respect to their binding and unbinding kinetics, i.e., with respect to their blocking and unblocking kinetics. This gives rise to different block-frequency relations and onset-kinetics of frequency-dependent ion channel blockade. Antiarrhythmic drugs have never been systematically compared with regard to their block-frequency relations. However, both the onset-kinetics as well as the block-frequency relation are essential in characterizing the frequency-dependent drug action, since both may be predictors of the anti- and pro-arrhythmic potential of antiarrhythmic drugs.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1520246     DOI: 10.1007/bf00804330

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  22 in total

1.  Differential analysis of the frequency-dependent effects of class 1 antiarrhythmic drugs according to periodical ligand binding: implications for antiarrhythmic and proarrhythmic efficacy.

Authors:  J Weirich; H Antoni
Journal:  J Cardiovasc Pharmacol       Date:  1990-06       Impact factor: 3.105

2.  Antiarrhythmic agents: modulated receptor applications.

Authors:  L M Hondeghem
Journal:  Circulation       Date:  1987-03       Impact factor: 29.690

3.  Theoretical characterization of ion channel blockade: ligand binding to periodically accessible receptors.

Authors:  C F Starmer
Journal:  J Theor Biol       Date:  1986-03-21       Impact factor: 2.691

4.  Mechanism of action of antifibrillatory drugs.

Authors:  P Heistracher
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

5.  Mechanisms of use-dependent block of sodium channels in excitable membranes by local anesthetics.

Authors:  C F Starmer; A O Grant; H C Strauss
Journal:  Biophys J       Date:  1984-07       Impact factor: 4.033

Review 6.  Channel specificity in antiarrhythmic drug action. Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias.

Authors:  T J Colatsky; C H Follmer; C F Starmer
Journal:  Circulation       Date:  1990-12       Impact factor: 29.690

7.  Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1989-08-10       Impact factor: 91.245

8.  Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence.

Authors:  L M Hondeghem; D J Snyders
Journal:  Circulation       Date:  1990-02       Impact factor: 29.690

9.  Ethacizin blockade of calcium channels: a test of the guarded receptor hypothesis.

Authors:  C F Starmer; A I Undrovinas; F Scamps; G Vassort; V V Nesterenko; L V Rosenshtraukh
Journal:  Am J Physiol       Date:  1989-11

10.  Dynamics of aminopyridine block of potassium channels in squid axon membrane.

Authors:  J Z Yeh; G S Oxford; C H Wu; T Narahashi
Journal:  J Gen Physiol       Date:  1976-11       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.